Arkolith/Insider Trading/ORIC/Form 4

Chacko Jacob

PRESIDENT AND CEO, DirectorOric Pharmaceuticals, Inc. (ORIC) · full profile →Form 4 · filed Feb 8, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$489K
Net Open-Market Flow
-$489K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 7, 2024Sell(S)26K$12.30$320K769K
Feb 6, 2024Sell(S)14K$12.12$169K795K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-003114) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML